blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0896580

EP0896580 - SPECIFIC IMMUNOPHILIN LIGANDS AS ANTIASTHMATICS AND IMMUNOSUPPRESSANTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.06.2003
Database last updated on 19.10.2024
Most recent event   Tooltip06.06.2003Application deemed to be withdrawnpublished on 23.07.2003  [2003/30]
Applicant(s)For all designated states
ASTA Medica Aktiengesellschaft
An der Pikardie 10
01277 Dresden / DE
[N/P]
Former [1999/07]For all designated states
ASTA Medica Aktiengesellschaft
An der Pikardie 10
D-01277 Dresden / DE
Inventor(s)01 / REICHERT, Dietmar
Elsavastrasse 79
D-63863 Eschau / DE
02 / KUTSCHER, Bernhard
Stresemannstrasse 9
D-63477 Maintal / DE
03 / BANG, Holger
Campingstrasse 2
D-91056 Erlangen / DE
04 / BRUNE, Kay
Weiherackerweg 17
D-91080 Marloffstein / DE
05 / QUINKERT, Gerhard
Schauinsland 32
D-61479 Glashütten 1 / DE
06 / SCHAIBLE, Hans-Günter
Rostocker Strasse 26
D-63486 Bruchköbel / DE
[1999/07]
Representative(s)Dey, Michael
Weickmann & Weickmann
Patent- und Rechtsanwälte PartmbB
Richard-Strauss-Strasse 80
81679 München / DE
[N/P]
Former [2001/21]Dey, Michael, Dr.
Weickmann & Weickmann, Patentanwälte, Postfach 86 08 20
81635 München / DE
Application number, filing date97916432.404.04.1997
[1999/07]
WO1997EP01681
Priority number, dateDE199611650925.04.1996         Original published format: DE 19616509
[1999/07]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO9741148
Date:06.11.1997
Language:DE
[1997/47]
Type: A1 Application with search report 
No.:EP0896580
Date:17.02.1999
Language:DE
The application published by WIPO in one of the EPO official languages on 06.11.1997 takes the place of the publication of the European patent application.
[1999/07]
Search report(s)International search report - published on:EP06.11.1997
ClassificationIPC:C07K5/06, C07D401/06, C07D209/42, C07D401/12, A61K31/40, A61K31/445, A61K38/05
[1999/07]
CPC:
C07D401/06 (EP,US); C07K5/06 (KR); A61P11/00 (EP);
A61P11/06 (EP); A61P37/00 (EP); A61P37/06 (EP);
A61P43/00 (EP); C07D209/42 (EP,US); C07D401/12 (EP,US);
C07K5/06139 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/07]
TitleGerman:SPEZIFISCHE IMMUNOPHILIN-LIGANDEN ALS ANTIASTHMATIKA, IMMUNSUPPRESSIVA[1999/07]
English:SPECIFIC IMMUNOPHILIN LIGANDS AS ANTIASTHMATICS AND IMMUNOSUPPRESSANTS[1999/07]
French:NOUVEAUX LIGANDS D'IMMUNOPHILINE SPECIFIQUES UTILISES COMME AGENTS ANTIASTHMATIQUES ET IMMUNOSUPPRESSIFS[1999/07]
Entry into regional phase15.07.1998National basic fee paid 
15.07.1998Designation fee(s) paid 
15.07.1998Examination fee paid 
Examination procedure18.07.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
15.07.1998Examination requested  [1999/07]
01.11.2002Application deemed to be withdrawn, date of legal effect  [2003/30]
05.12.2002Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2003/30]
Fees paidRenewal fee
22.04.1999Renewal fee patent year 03
27.04.2000Renewal fee patent year 04
30.04.2001Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.04.200206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]FR2585709  (ADIR [FR], et al) [X] 1,13,15-19 * examples 11-13 *;
 [X]EP0320753  (HOECHST AG [DE]) [X] 1,13,15-19 * the whole document *;
 [X]FR2681864  (ADIR [FR]) [X] 1,13,15-19 * the whole document *;
 JPH06227980  [ ] (MEIJI SEIKA KAISHA);
 [X]EP0618193  (ADIR [FR]) [X] 1,13,15-19 * examples 11-14 *;
 [PX]US5547978  (CHRISTENSEN BURTON G [US], et al) [PX] 1,13,15-19* the whole document *;
 [PX]  - B PORTEVIN ET AL., "new prollyl endopeptidase inhibitors; in vitro and in vivo activities of azabiciclo[2.2.2]octane, azabiciclo[2.2.1]heptane and perhydrohindole derivatives", JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON US, (19960607), vol. 39, no. 12, pages 2379 - 2391, XP002036250 [PX] 1,13,15-19 * the whole document *

DOI:   http://dx.doi.org/10.1021/jm950858c
 [X]  - CHEMICAL ABSTRACTS, (19950911), vol. 123, no. 11, Database accession no. 144641r, XP002036251 [X] 1,13,15-19 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.